Dyne therapeutics news
WebApr 11, 2024 · A high-level overview of Dyne Therapeutics, Inc. (DYN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … WebApr 13, 2024 · Dyne Therapeutics Inc (DYN) stock is trading at $8.97 as of 3:43 PM on Thursday, Apr 13, a gain of $0.44, or 5.19% from the previous closing price of $8.53. The …
Dyne therapeutics news
Did you know?
WebApr 4, 2024 · Dyne Therapeutics Stock Performance. Shares of DYN stock opened at $11.05 on Tuesday. The firm’s 50-day moving average is $13.08 and its 200-day moving average is $12.22. The stock has a market ... WebDyne Therapeutics Inc Working Capital Per Revenue on the trailing twelve month basis from the forth quarter 2024 to forth quarter 2024, Trends and Ranking, Fundamental Ratios - CSIMarket
WebApr 11, 2024 · Ashburn, Virginia, United States, April 11, 2024 (GLOBE NEWSWIRE) -- Domo Tactical Communications (DTC), a CODAN company, has entered into a supply … WebApr 10, 2024 · 5 brokerages have issued twelve-month target prices for Dyne Therapeutics' shares. Their DYN share price forecasts range from $18.00 to $34.00. On average, they …
WebApr 11, 2024 · Let’s start up with the current stock price of Dyne Therapeutics Inc. (DYN), which is $8.82 to be very precise. The Stock rose vividly during the last session to $9.35 … WebMar 20, 2024 · WALTHAM, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on …
WebDyne Therapeutics 7,996 followers 1y Report this post Report Report. Back ...
WebMar 20, 2024 · Dyne links therapeutic payloads to its TfR1-binding fragment antibody (Fab) to develop targeted therapeutics for muscle diseases. About DYNE-101 and the ACHIEVE Trial. DYNE-101 is an investigational therapeutic being evaluated in the Phase 1/2 global ACHIEVE trial, for people living with myotonic dystrophy type 1 (DM1). small bible study lessonsWebMar 20, 2024 · WALTHAM, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. DYN, a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people ... small bicycle air pumpWebMar 2, 2024 · - Data Anticipated in the Second Half of 2024 from ACHIEVE Clinical Trial of DYNE-101 in DM1 and DELIVER Clinical Trial of DYNE-251 in DMD - WALTHAM, Mass., March 02, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life … small bicycle dog trailerWebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. small bible study topicsWebMar 23, 2024 · Dyne Therapeutics, Inc. announced that DYNE-251, an investigational therapeutic for Duchenne muscular dystrophy mutations amenable to exon 51 skipping, was granted FDA orphan drug and rare pediatric disease designations.DYNE-251 is being evaluated in the Phase 1/2 DELIVER clinical trial. Under the FDA's rare pediatric disease … small bicycle freewheelWebDec 15, 2024 · The Trade: Dyne Therapeutics, Inc. (NASDAQ:DYN) Director Jason Rhodes acquired a total of 934,581 shares at an average price of $10.70. To acquire these shares, it cost around $10 million. What ... solomon islands national development planWeb19 hours ago · Other News for DYN Dyne Therapeutics management to meet with Oppenheimer 03/31/23-3:55AM EST Thefly.com Dyne Therapeutics management to … solomon islands national ocean policy